Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer

NCT00751790 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasm

Interventions

DRUG: triptorelin embonate (INN)

Sponsor

Debiopharm International SA